{"transactions":[{"id":992552,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-20T16:05:38.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":2545,"price":2.983,"value":7591.735,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":299064,"source":{"system":"sec-edgar","filing":"0001140361-25-042856","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125042856/form4.xml","form_type":"4"}},{"id":1044848,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-09T16:15:04.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":301609,"source":{"system":"sec-edgar","filing":"0001140361-25-034420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125034420/form4.xml","form_type":"4"}},{"id":1060331,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-20T17:00:22.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":805,"price":2.996,"value":2411.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":221609,"source":{"system":"sec-edgar","filing":"0001140361-25-032091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125032091/form4.xml","form_type":"4"}},{"id":1060330,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-20T17:00:22.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1680,"price":3.065,"value":5149.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":222414,"source":{"system":"sec-edgar","filing":"0001140361-25-032091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125032091/form4.xml","form_type":"4"}},{"id":1063985,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-18T16:35:04.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":11161,"price":3.019,"value":33695.059,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":224094,"source":{"system":"sec-edgar","filing":"0001140361-25-031762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125031762/form4.xml","form_type":"4"}},{"id":1137226,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-22T16:05:46.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":801,"price":6.446,"value":5163.246,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":235255,"source":{"system":"sec-edgar","filing":"0001140361-25-020162","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125020162/form4.xml","form_type":"4"}},{"id":1140502,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-20T16:05:42.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":1582,"price":6.528,"value":10327.296,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":236056,"source":{"system":"sec-edgar","filing":"0001140361-25-019900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125019900/form4.xml","form_type":"4"}},{"id":1240796,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-27T16:01:15.000Z","date":"2025-02-25","kind":"sale","planned":false,"acquired":false,"shares":6532,"price":10.58,"value":69108.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Inclusive of the acquisition of 80,318 RSUs that convert to common stock on a one-for-one basis, as reported on the Reporting Person's Form 4 filed on 02/13/2025."}],"balance_after":237638,"source":{"system":"sec-edgar","filing":"0001140361-25-006272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125006272/form4.xml","form_type":"4"}},{"id":1240795,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-27T16:01:15.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":3097,"price":13.05,"value":40415.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":163852,"source":{"system":"sec-edgar","filing":"0001140361-25-006272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125006272/form4.xml","form_type":"4"}},{"id":1240794,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-27T16:01:15.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":2710,"price":18.5,"value":50135.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":166949,"source":{"system":"sec-edgar","filing":"0001140361-25-006272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125006272/form4.xml","form_type":"4"}},{"id":1240793,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-27T16:01:15.000Z","date":"2024-05-17","kind":"sale","planned":false,"acquired":false,"shares":2754,"price":23.35,"value":64305.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":169659,"source":{"system":"sec-edgar","filing":"0001140361-25-006272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125006272/form4.xml","form_type":"4"}},{"id":1269692,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T16:01:34.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":119682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 119,682 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":119682,"derivative":{"exercise_price":9.88,"expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":119682},"source":{"system":"sec-edgar","filing":"0001140361-25-004295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125004295/form4.xml","form_type":"4"}},{"id":1269691,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-13T16:01:34.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":80318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":252731,"source":{"system":"sec-edgar","filing":"0001140361-25-004295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036125004295/form4.xml","form_type":"4"}},{"id":1742351,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T20:59:36.000Z","date":"2023-11-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60806,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the consummation of the Merger, pursuant to the Merger Agreement, 60,806 unvested restricted stock awards (\"RSAs\") were cancelled and converted into the right to receive a cash payment of $638,463, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-015129","document":"form4-11152023_011129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000141588923015129/form4-11152023_011129.xml","form_type":"4"}},{"id":1742350,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T20:59:36.000Z","date":"2023-11-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17582,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the consummation of the merger (the \"Merger\") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the \"Company\"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the \"Merger Agreement\"), 17,582 shares of common stock of the Company (\"Common Stock\") were converted into the right to receive a cash payment of $184,611, representing the product obtained by multiplying (x) the number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50)."}],"balance_after":60806,"source":{"system":"sec-edgar","filing":"0001415889-23-015129","document":"form4-11152023_011129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000141588923015129/form4-11152023_011129.xml","form_type":"4"}},{"id":1857273,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T16:33:20.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":25641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a restricted stock award of 25,641 shares of the Company's common stock on June 9, 2023. Such common stock will vest in full on the one-year anniversary of the grant date."}],"balance_after":78388,"source":{"system":"sec-edgar","filing":"0001415889-23-009747","document":"form4-06132023_080617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000141588923009747/form4-06132023_080617.xml","form_type":"4"}},{"id":2000006,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-22T19:28:17.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":3557,"price":19.06,"value":67796.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":94546,"source":{"system":"sec-edgar","filing":"0001140361-23-008104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123008104/form4.xml","form_type":"4"}},{"id":2000005,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T19:25:59.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":8574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":17410,"derivative":{"underlying":"Common Stock","underlying_shares":8574},"source":{"system":"sec-edgar","filing":"0001140361-23-008101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123008101/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2000004,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T19:25:59.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":41541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":41541,"derivative":{"underlying":"Common Stock","underlying_shares":41541},"source":{"system":"sec-edgar","filing":"0001140361-23-008101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123008101/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2000003,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-22T19:25:59.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":124496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 124,496 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":124496,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":124496},"source":{"system":"sec-edgar","filing":"0001140361-23-008101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123008101/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2000002,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-22T19:25:59.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":8574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit award."}],"balance_after":98103,"source":{"system":"sec-edgar","filing":"0001140361-23-008101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123008101/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2011067,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-16T16:45:38.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":41541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":41541,"derivative":{"underlying":"Common Stock","underlying_shares":41541},"source":{"system":"sec-edgar","filing":"0001140361-23-007484","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123007484/form4.xml","form_type":"4"}},{"id":2011066,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T16:45:38.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":124496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 124,496 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":124496,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":124496},"source":{"system":"sec-edgar","filing":"0001140361-23-007484","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036123007484/form4.xml","form_type":"4"}},{"id":2158456,"issuer":{"id":108300,"kind":"organization","name":"Tabula Rasa HealthCare, Inc.","symbol":"TRHC"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-15T21:06:53.000Z","date":"2022-09-13","kind":"grant","acquired":true,"shares":52747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Tabula Rasa HealthCare, Inc. Non-Employee Director Compensation Policy (the \"Policy\"), the reporting person received an Initial Equity Award (as such term is defined in the Policy) of 52,747 shares of restricted stock of the issuer's common stock in connection with the reporting person's appointment to the issuer's Board of Directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock awards vest in three substantially equal annual installments on September 13, 2023, September 13, 2024, and September 13, 2025."}],"balance_after":52747,"source":{"system":"sec-edgar","filing":"0001415889-22-009692","document":"form4-09152022_060943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000141588922009692/form4-09152022_060943.xml","form_type":"4"}},{"id":2184318,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-08-16T17:33:53.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":22896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."}],"balance_after":22896,"derivative":{"underlying":"Common Stock","underlying_shares":22896},"source":{"system":"sec-edgar","filing":"0001140361-22-029894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122029894/form4.xml","form_type":"4"}},{"id":2308428,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":32026,"price":16.2,"value":518821.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"kind","element":"transactionCoding","label":"F2","text":"The original Form 4, filed on April 1, 2022, is being amended by this amendment to include additional transactions that were effected pursuant to the 10b5-1 Plan on March 31, 2022 and April 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.00 to $16.45, inclusive."}],"balance_after":89529,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2308427,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":12974,"price":15.86,"value":205767.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"kind","element":"transactionCoding","label":"F2","text":"The original Form 4, filed on April 1, 2022, is being amended by this amendment to include additional transactions that were effected pursuant to the 10b5-1 Plan on March 31, 2022 and April 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.70 to $15.99, inclusive."}],"balance_after":121555,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2308426,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":35998,"price":16.15,"value":581367.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"kind","element":"transactionCoding","label":"F2","text":"The original Form 4, filed on April 1, 2022, is being amended by this amendment to include additional transactions that were effected pursuant to the 10b5-1 Plan on March 31, 2022 and April 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.00 to $16.45, inclusive."}],"balance_after":134529,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2308425,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":9002,"price":15.9,"value":143131.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"kind","element":"transactionCoding","label":"F2","text":"The original Form 4, filed on April 1, 2022, is being amended by this amendment to include additional transactions that were effected pursuant to the 10b5-1 Plan on March 31, 2022 and April 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.83 to $15.99, inclusive."}],"balance_after":170527,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2308424,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":34438,"price":16.56,"value":570293.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.00 to $16.95, inclusive."}],"balance_after":179529,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2308423,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T07:37:27.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":10562,"price":15.94,"value":168358.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to amend and restate the footnote (1) in the original Form 4, filed on April 1, 2022, in its entirety as follows: \"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified (the \"10b5-1 Plan\"), under which the reporting person has irrevocably elected to satisfy the tax obligations through these sales and do not represent discretionary trades by the reporting person.\""},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.87 to $15.99, inclusive. The reporting person undertakes to provide to Rocket Pharmaceuticals, Inc., any securityholder of Rocket Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3, 4, 5, 6, 7 and 8 to this Form 4."}],"balance_after":213967,"source":{"system":"sec-edgar","filing":"0001140361-22-012779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012779/form4.xml","form_type":"4/A","original_submission_date":"2022-04-01"}},{"id":2311324,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-01T16:51:50.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":34438,"price":16.56,"value":570293.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.00 to $16.95, inclusive."}],"balance_after":179529,"source":{"system":"sec-edgar","filing":"0001140361-22-012640","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012640/form4.xml","form_type":"4"}},{"id":2311323,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-01T16:51:50.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":10562,"price":15.94,"value":168358.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2021, as modified."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.87 to $15.99, inclusive. The reporting person undertakes to provide to Rocket Pharmaceuticals, Inc., any securityholder of Rocket Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4."}],"balance_after":213967,"source":{"system":"sec-edgar","filing":"0001140361-22-012640","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122012640/form4.xml","form_type":"4"}},{"id":2391984,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-16T21:02:50.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":25984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":25984,"derivative":{"underlying":"Common Stock","underlying_shares":25984},"source":{"system":"sec-edgar","filing":"0001140361-22-005825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122005825/form4.xml","form_type":"4"}},{"id":2391983,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T21:02:50.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":81010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 81,010 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":81010,"derivative":{"exercise_price":20,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":81010},"source":{"system":"sec-edgar","filing":"0001140361-22-005825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036122005825/form4.xml","form_type":"4"}},{"id":2874583,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T20:34:08.000Z","date":"2021-02-04","kind":"disposition_to_issuer","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 35,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":62.32,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-21-003780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036121003780/form4.xml","form_type":"4"}},{"id":2882060,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T21:06:23.000Z","date":"2020-02-10","kind":"disposition_to_issuer","acquired":false,"shares":213101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 251,410 shares of the Issuer's Common Stock 83,803 of which became fully vested and exercisable on February 8, 2017, with the remaining 167,607 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":38309,"derivative":{"exercise_price":1.21,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":213101},"source":{"system":"sec-edgar","filing":"0001140361-21-003321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036121003321/form4.xml","form_type":"4"}},{"id":2882059,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T21:06:23.000Z","date":"2021-02-01","kind":"disposition_to_issuer","acquired":false,"shares":11428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 11,428 shares of the Issuer's Common Stock 4,113 of which will become fully vested and exercisable on April 12, 2018, with the remaining 7,315 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":11428},"source":{"system":"sec-edgar","filing":"0001140361-21-003321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036121003321/form4.xml","form_type":"4"}},{"id":2882058,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:06:23.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":213101,"price":1.21,"value":257852.21,"ownership":{"direct":true},"balance_after":224529,"source":{"system":"sec-edgar","filing":"0001140361-21-003321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036121003321/form4.xml","form_type":"4"}},{"id":2882057,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:06:23.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":11428,"price":1.69,"value":19313.32,"ownership":{"direct":true},"balance_after":11428,"source":{"system":"sec-edgar","filing":"0001140361-21-003321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036121003321/form4.xml","form_type":"4"}},{"id":3282204,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T17:07:35.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 10, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":7000,"derivative":{"exercise_price":23.89,"expiration_date":"2030-02-10","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-008017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000120919120008017/doc4.xml","form_type":"4"}},{"id":3282203,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T17:07:35.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":22.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-008017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000120919120008017/doc4.xml","form_type":"4"}},{"id":3423399,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-04T16:22:59.000Z","date":"2019-09-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, 10,000 of which will become fully vested and exercisable on September 2, 2020, with the remaining 20,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":30000,"derivative":{"exercise_price":10.85,"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-048190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000120919119048190/doc4.xml","form_type":"4"}},{"id":3682689,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T18:48:35.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, 25,000 of which will become fully vested and exercisable on January 28, 2020, with the remaining 50,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-19-002016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000114036119002016/form4.xml","form_type":"4"}},{"id":3976622,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":72815,"kind":"person","name":"Schwartz Jonathan David","position":1,"cik":"0001726398","reported_name":"Schwartz Jonathan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-02T20:07:50.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 60,000 shares of the Issuer's Common Stock, 20,000 of which will become fully vested and exercisable on March 29, 2019, with the remaining 40,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-18-009111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726398/000089924318009111/doc4.xml","form_type":"4"}}]}